Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Biotech
iTeos drops one of 3 clinical assets from pipeline
iTeos is deprioritizing a phase 2 NSCLC asset after it failed to meet the biotech's bar for further investment.
Gabrielle Masson
Dec 12, 2024 3:10pm
GSK pays AI biotech $45M upfront to identify fibrotic targets
Dec 10, 2024 4:59am
GSK pays Muna $35M cash to chase new Alzheimer's drug targets
Dec 5, 2024 7:00am
GSK goes East again, snagging option on DualityBio ADC for $30M
Dec 4, 2024 8:20am
GSK offers Rgenta up to $500M biobucks per target in RNA deal
Dec 4, 2024 8:00am
GSK axes hepatitis B vaccine trial after missing efficacy goal
Dec 4, 2024 5:15am
